On July 16, 2010, the Food and Drug Administration (FDA) decided to keep the diabetes drug Avandia (rosiglitazone) on the market despite a cardiovascular threat to some patients. Conflicting studies have shown that the drug rosiglitazone promotes increased cardiovascular risk to patients with diabetes. The FDA, as well as the Endocrine Society, the American Association of Clinical Endocrinologists and the American Diabetes Association, have issued warnings that stopping the...

Prescription drug manufacturer American Regent has issued a voluntary recall of every lot of their ketorolac tromethamine injection, 30 mg/ml product. The US Food and Drug Administration (FDA) announced recently that particulate matter and crystallization might be present in the drug that could result in obstruction of blood vessels. If a person injects the drug and particulate matter and crystallization is present, it could induce pulmonary emboli or thrombosis...

This Newsday article claims that the McNeil unit of Johnson & Johnson has voluntarily recalled 57 lots of infants and children’s liquid Tylenol products due to the possibility of bacterial contamination. The Tylenol products manufactured between April and June 2009 included almost two dozen varieties subject to the recall. Johnson & Johnson has said publicly that an inactive ingredient in the various types of product did not meet the...